Literature DB >> 27390227

Impact of type 2 diabetes mellitus on recurrent myocardial infarction in China.

Wentao Li1, Muwei Li1, Chuanyu Gao2, Xianpei Wang1, Datun Qi1, Jun Liu1, Qiangsong Jin3.   

Abstract

To evaluate the influence of type 2 diabetes mellitus on the long-term outcomes of Chinese patients with previous myocardial infarction, we studied 864 patients with previous myocardial infarction, including 251 with type 2 diabetes mellitus and 613 without type 2 diabetes mellitus, over a median follow-up time of 2.9 years. The type 2 diabetes mellitus patients were subdivided into 95 insulin-treated diabetes mellitus and 156 non-insulin-treated diabetes mellitus subjects. The crude incidences (per 1000 patient-years) in the type 2 diabetes mellitus subjects versus the non-type 2 diabetes mellitus subjects were 43.7 versus 25.1 for recurrent myocardial infarction, 68.7 versus 28.3 for all-cause death and 99.8 versus 49.9 for the composite end point (i.e. recurrent myocardial infarction or all-cause death). Cox regression analysis showed that the adjusted hazard ratios for recurrent myocardial infarction, all-cause death and their combination were 1.67 (95% confidence interval: 1.06-2.74), 1.90 (1.25-2.90) and 1.72 (1.23-2.40), respectively. Significant associations were also observed between insulin treatment and all-cause death. Our findings suggested that type 2 diabetes mellitus is an independent risk factor for recurrent myocardial infarction, all-cause death and the composite end point among previous myocardial infarction patients.
© The Author(s) 2016.

Entities:  

Keywords:  Type 2 diabetes mellitus; insulin; myocardial infarction; prognosis

Mesh:

Substances:

Year:  2016        PMID: 27390227     DOI: 10.1177/1479164116653606

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN: 1479-1641            Impact factor:   3.291


  6 in total

1.  Clinical Significance of Serum PGC-1 Alpha Levels in Diabetes Mellitus with Myocardial Infarction Patients and Reduced ROS-Oxidative Stress in Diabetes Mellitus with Myocardial Infarction Model.

Authors:  Ning Zhu; Xue Yan; Hongli Li; Huiqin Wang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-28       Impact factor: 3.168

2.  Circulating Prolidase Activity in Patients with Myocardial Infarction.

Authors:  Adnan Sultan; Yuting Zheng; Patrick J Trainor; Yong Siow; Alok R Amraotkar; Bradford G Hill; Andrew P DeFilippis
Journal:  Front Cardiovasc Med       Date:  2017-07-31

3.  Long Noncoding RNA SOX2-OT Exacerbates Hypoxia-Induced Cardiomyocytes Injury by Regulating miR-27a-3p/TGFβR1 Axis.

Authors:  Guang Yang; Chunsheng Lin
Journal:  Cardiovasc Ther       Date:  2020-05-06       Impact factor: 3.023

4.  The Distributional Characteristics of M2 Macrophages in the Placental Chorionic Villi are Altered Among the Term Pregnant Women With Uncontrolled Type 2 Diabetes Mellitus.

Authors:  Muqiu Zhang; Dong Cui; Huixia Yang
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

Review 5.  Prognostic implications for patients after myocardial infarction: an integrative literature review and in-depth interviews with patients and experts.

Authors:  Seon Young Hwang; Sun Hwa Kim; In Ae Uhm; Jeong-Hun Shin; Young-Hyo Lim
Journal:  BMC Cardiovasc Disord       Date:  2022-08-02       Impact factor: 2.174

6.  Cost-Effectiveness of Alirocumab for the Secondary Prevention of Cardiovascular Events after Myocardial Infarction in the Chinese Setting.

Authors:  Zhe Liang; Qi Chen; Ruiqi Wei; Chenyao Ma; Xuehui Zhang; Xue Chen; Fang Fang; Quanming Zhao
Journal:  Front Pharmacol       Date:  2021-04-14       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.